Is HealthEquity Stock a Good Investment?
HealthEquity Investment Advice | HQY |
- Examine HealthEquity's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research HealthEquity's leadership team and their track record. Good management can help HealthEquity navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact HealthEquity's business and its evolving consumer preferences.
- Compare HealthEquity's performance and market position to its competitors. Analyze how HealthEquity is positioned in terms of product offerings, innovation, and market share.
- Check if HealthEquity pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about HealthEquity's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in HealthEquity stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if HealthEquity is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Weakest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Tiny | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine HealthEquity Stock
Researching HealthEquity's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The book value of HealthEquity was currently reported as 24.84. The company has Price/Earnings To Growth (PEG) ratio of 1.1. HealthEquity had not issued any dividends in recent years.
To determine if HealthEquity is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding HealthEquity's research are outlined below:
| HealthEquity generated a negative expected return over the last 90 days | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Why HealthEquity is a Top Growth Stock for the Long-Term |
HealthEquity Quarterly Cash And Short Term Investments |
|
HealthEquity uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in HealthEquity. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to HealthEquity's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 3rd of June 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 19th of March 2024 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 31st of January 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact HealthEquity's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises HealthEquity's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2016-12-06 | 2016-10-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2015-12-07 | 2015-10-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2015-09-08 | 2015-07-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2015-06-08 | 2015-04-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2015-03-24 | 2015-01-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2014-12-09 | 2014-10-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2018-03-19 | 2018-01-31 | 0.09 | 0.11 | 0.02 | 22 | ||
2016-06-07 | 2016-04-30 | 0.13 | 0.15 | 0.02 | 15 |
HealthEquity Target Price Consensus
HealthEquity target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. HealthEquity's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Strong Buy |
Most HealthEquity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand HealthEquity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of HealthEquity, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationHealthEquity Target Price Projection
HealthEquity's current and average target prices are 96.53 and 122.36, respectively. The current price of HealthEquity is the price at which HealthEquity is currently trading. On the other hand, HealthEquity's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
HealthEquity Market Quote on 29th of September 2025
Target Price
Analyst Consensus On HealthEquity Target Price
HealthEquity Analyst Ratings
HealthEquity's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about HealthEquity stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of HealthEquity's financials, market performance, and future outlook by experienced professionals. HealthEquity's historical ratings below, therefore, can serve as a valuable tool for investors.Know HealthEquity's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as HealthEquity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HealthEquity backward and forwards among themselves. HealthEquity's institutional investor refers to the entity that pools money to purchase HealthEquity's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Mackenzie Investments | 2025-06-30 | 1.3 M | Westfield Capital Management Company, L.p. | 2025-06-30 | 1.3 M | Citadel Advisors Llc | 2025-06-30 | 1.2 M | Charles Schwab Investment Management Inc | 2025-06-30 | 1.1 M | Atlantic Trust Group, Llc | 2025-06-30 | 1.1 M | Geneva Capital Management | 2025-06-30 | 1.1 M | Aqr Capital Management Llc | 2025-06-30 | 1.1 M | Northern Trust Corp | 2025-06-30 | 1.1 M | Jpmorgan Chase & Co | 2025-06-30 | 1.1 M | Blackrock Inc | 2025-06-30 | 10.7 M | Vanguard Group Inc | 2025-06-30 | 8.5 M |
HealthEquity's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 8.32 B.Market Cap |
|
HealthEquity's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.16 | 0.13 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.05 | 0.08 |
Determining HealthEquity's profitability involves analyzing its financial statements and using various financial metrics to determine if HealthEquity is a good buy. For example, gross profit margin measures HealthEquity's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of HealthEquity's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in HealthEquity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of HealthEquity. Check HealthEquity's Beneish M Score to see the likelihood of HealthEquity's management manipulating its earnings.
Evaluate HealthEquity's management efficiency
HealthEquity has Return on Asset of 0.0494 % which means that on every $100 spent on assets, it made $0.0494 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0678 %, implying that it generated $0.0678 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 0.08 in 2025, whereas Return On Tangible Assets are likely to drop 0.13 in 2025. At this time, HealthEquity's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 3.1 B in 2025, whereas Other Assets are likely to drop 1.09 in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 24.35 | 25.56 | |
| Tangible Book Value Per Share | (8.49) | (8.07) | |
| Enterprise Value Over EBITDA | 30.82 | 26.52 | |
| Price Book Value Ratio | 4.54 | 5.59 | |
| Enterprise Value Multiple | 30.82 | 26.52 | |
| Price Fair Value | 4.54 | 5.59 | |
| Enterprise Value | 5 B | 5.2 B |
At HealthEquity, management's focus on innovation and efficiency has led to impressive financial results. We assess these factors to determine the stock's attractiveness to investors.
Beta 0.504 |
Basic technical analysis of HealthEquity Stock
As of the 29th of September, HealthEquity retains the risk adjusted performance of (0.02), and Market Risk Adjusted Performance of (0.13). HealthEquity technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.HealthEquity's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific HealthEquity insiders, such as employees or executives, is commonly permitted as long as it does not rely on HealthEquity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases HealthEquity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
HealthEquity's Outstanding Corporate Bonds
HealthEquity issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HealthEquity uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HealthEquity bonds can be classified according to their maturity, which is the date when HealthEquity has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HEALTHCARE TRUST OF Corp BondUS42225UAH77 | View | |
| US42225UAG94 Corp BondUS42225UAG94 | View | |
| HR 3625 15 JAN 28 Corp BondUS42225UAK07 | View | |
| HR 205 15 MAR 31 Corp BondUS42225UAM62 | View | |
| HR 24 15 MAR 30 Corp BondUS42225UAL89 | View | |
| HEALTHCARE TR AMER Corp BondUS42225UAD63 | View | |
| HEALTHCARE TR AMER Corp BondUS42225UAF12 | View | |
| US42226AAA51 Corp BondUS42226AAA51 | View |
Understand HealthEquity's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing HealthEquity's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 1.62 | |||
| Coefficient Of Variation | (2,511) | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.91 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 13.9 | |||
| Value At Risk | (3.04) | |||
| Potential Upside | 2.98 | |||
| Skewness | 0.001 | |||
| Kurtosis | 2.15 |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 1.62 | |||
| Coefficient Of Variation | (2,511) | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.91 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 13.9 | |||
| Value At Risk | (3.04) | |||
| Potential Upside | 2.98 | |||
| Skewness | 0.001 | |||
| Kurtosis | 2.15 |
Consider HealthEquity's intraday indicators
HealthEquity intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of HealthEquity stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
HealthEquity Corporate Filings
F4 | 22nd of September 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 2nd of September 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 14th of July 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 13th of May 2025 Other Reports | ViewVerify |
HealthEquity Stock media impact
There is far too much social signal, news, headlines, and media speculation about HealthEquity that are available to investors today. This information is accessible both publicly - through HealthEquity's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of HealthEquity-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of HealthEquity news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of HealthEquity relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to HealthEquity's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive HealthEquity alpha.
HealthEquity Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards HealthEquity can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
HealthEquity Historical Investor Sentiment
Investor biases related to HealthEquity's public news can be used to forecast risks associated with an investment in HealthEquity. The trend in average sentiment can be used to explain how an investor holding HealthEquity can time the market purely based on public headlines and social activities around HealthEquity. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
HealthEquity's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for HealthEquity and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average HealthEquity news discussions. The higher the estimate score, the more favorable the investor's outlook on HealthEquity.
HealthEquity Maximum Pain Price Across December 19th 2025 Option Contracts
HealthEquity's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of HealthEquity close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of HealthEquity's options.
HealthEquity Corporate Management
| Cheryl King | Executive Officer | Profile | |
| Tia Padia | Executive Officer | Profile | |
| Richard Putnam | IR Contact Officer | Profile | |
| Jeff Venuti | New Consultant | Profile |
Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.